Mesoblast Limited Revenue per Employee (MESO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mesoblast Limited  (NASDAQ: MESO)
 

Mesoblast Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Mesoblast Limited's Revenue per employee fell on a trailing twelve month basis to $ 159,241, below the company average number of $69,047.
Within the Healthcare sector Employees of 442 other companies have achieved higher revenue per employee. While Mesoblast Limited's total ranking has deteriorated compared to the previous quarter from 2557 to 3268. Mesoblast Limited has 108 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MESO Revenue per Employee (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Revenue Change 191.39 % - - - -21.32 %
Sales per Employee (TTM) $ 159,241 54,648 54,648 54,648 54,648
MESO's Total Ranking # 3268 # 2557 # # #
Seq. Revenue Change - - - - -

MESO Company Profile >> Back to MESO Efficiency Comparisons >> Compare MESO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 443
Overall Market # 3268

Revenue per Employee Statistics
High Average Low
$ 159,980 $ 69,047 $ 29,363
(Jun 30 2020)   (Jun 30 2024)



Financial Statements
Mesoblast Limited's Revenue MRQ $ 17 Millions Visit MESO's Income Statement
Mesoblast Limited's Revenues TTM $ 17 Millions Visit MESO's aggregate revenue growth
What are MESO's Sales? Visit MESO's Sales by Segment




Other Ratios
Mesoblast Limited's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MESO's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MESO's Competitors
Revenue per Employee for MESO's Suppliers
Revenue per Employee for MESO's Customers

You may also want to know
MESO's Sales Growth Rates MESO's Pe Price to earnings ratio MESO's Receivables Turnover Ratio MESO's Stock Quote
MESO's Net Income Growth Rates MESO's Ps Price to Sales ratio MESO's Sales per Employee MESO's Asset Turnover Ratio
MESO's Net Margin MESO's Pb Price to Book ratio MESO's Financial Strength Ratios MESO's Dividend Payout Ratio
Date modified: 2026-07-07T12:24:10+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Genedx Holdings Corp   278,009.23 $ 361.412  Million 1,300 
Orasure Technologies Inc  276,354.00 $ 138.177  Million 500 
Tactile Systems Technology Inc   274,673.11 $ 298.295  Million 1,086 
Cryoport inc   274,647.70 $ 202.690  Million 738 
Protalix Biotherapeutics inc   274,106.19 $ 61.948  Million 226 
West Pharmaceutical Services Inc   273,990.74 $ 2,959.100  Million 10,800 
Irhythm Holdings Inc   273,590.42 $ 656.617  Million 2,400 
Arcellx Inc   272,626.79 $ 56.979  Million 209 
Penumbra Inc  272,372.77 $ 1,280.152  Million 4,700 
The Cooper Companies Inc   269,786.67 $ 4,046.800  Million 15,000 
Champions Oncology Inc   265,785.05 $ 56.878  Million 214 
Quanterix Corporation  265,471.34 $ 125.037  Million 471 
Adaptimmune Therapeutics Plc  264,573.17 $ 65.085  Million 246 
Quipt Home Medical Corp   264,350.63 $ 422.961  Million 1,600 
Syndax Pharmaceuticals Inc   262,348.99 $ 78.180  Million 298 
Dentsply Sirona Inc   262,214.29 $ 3,671.000  Million 14,000 
Harvard Bioscience Inc   261,041.30 $ 88.493  Million 339 
Exagen Inc   259,777.27 $ 57.151  Million 220 
Omniab Inc   258,730.34 $ 23.027  Million 89 
Healthlynked Corp  257,561.90 $ 2.576  Million 10 
Cytosorbents Corporation  254,468.34 $ 32.826  Million 129 
Revvity Inc  254,406.09 $ 2,798.467  Million 11,000 
Vycor Medical Inc   254,115.57 $ 1.779  Million 7 
Jaguar Health Inc   251,276.60 $ 11.810  Million 47 
Zimvie Inc   250,509.60 $ 443.402  Million 1,770 
Cvrx inc   249,587.44 $ 55.658  Million 223 
Gossamer Bio Inc   248,376.54 $ 40.237  Million 162 
Iovance Biotherapeutics inc   247,717.95 $ 241.525  Million 975 
Inotiv Inc   246,969.21 $ 505.299  Million 2,046 
Ardent Health Inc   245,976.98 $ 6,198.620  Million 25,200 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.